Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors-Reference-Cited by-同舟云学术

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors

Published:2016-10-25 Issue:14 Volume:8 Page:23851-23861
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Vo Kieuhoa T.¹,Karski Erin E.¹,Nasholm Nicole M.¹,Allen Shelly¹,Hollinger Fabienne¹,Clay Gustafson W.¹,Long-Boyle Janel R.²,Shiboski Stephen³,Matthay Katherine K.¹,DuBois Steven G.¹

Affiliation:

1. Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, CA, USA

2. Department of Clinical Pharmacy, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, CA, USA

3. Department of Epidemiology and Biostatistics, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, CA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer;European Journal of Cancer;2024-08

2. Metronomic chemotherapy in pediatric neurooncology: insight the problem. A review;Journal of Modern Oncology;2024-07-03

3. Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma;Cancer Letters;2024-04

4. Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review;Journal of Modern Oncology;2024-02-21

5. A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors;Pediatric Blood & Cancer;2023-05-09